TNF inhibitor
Date |
Type | Title | Save |
|---|---|---|---|
| 11 Feb 2019 | ACR Video | QD Clinic - Breast Cancer & a TNF Inhibitor | |
| 06 Feb 2019 | Social | The EMAs CHMP has issued a eceived a positive opinion for 2 TNF inhibitor biosimilars: Idacio (adalimumab) and Kromeya (adalimumab). For the treatment of select inflammatory and autoimmune disorders https://t.co/lz7EvtTcTB | |
| 24 Jan 2019 | Social | Using FMF-KI knockout mice (high TNF levels) researchers find TNF signaling drives pyrin & inflammasome activation; TNF is a critical modulator of pyrin of pyrin-inflammasomopathies like FMF. This is why TNF inhib sometimes work in inflammasomopathies. https://t.co/0EvuTI57tn | |
| 19 Dec 2018 | Social | Study from the UK BSRBR registry shows 34 cancers & 41 deaths in 709 pts. Risk of CA w/ TNFi was not increased (SIR 0.94; 95% CI 0.65,1.34) (but for 2 fold incr risk of nonmelanoma skin CA) & all-cause mortality rate was increased (SMR 1.56) from CV events https://t.co/6HSnw5SOF8 | |
| 25 Oct 2018 | Social | RT @WIRheum: MTB screening in patients on TNFi When to re-screen? Neg to pos conversion discovered in a small number of cases Often in p… | |
| 25 Oct 2018 | Social | RT @NicoleBitencou5: Use of antiTNF in childhood does NOT appear to increase risk of malignancy in adults according to Medicare claims data… | |
| 23 Oct 2018 | ACR Video | Dr. Janet Pope: TB Testing and TNF Inhibitors | |
| 21 Aug 2018 | Social | TB Study of 550 RA, PsA, AS patients on TNF inhibitors from Romania (population risk is 97 per100k PY): incidence of TB on TNFi to be 1348.0, 862.1 and 540.2 per 100k Pt-Yrs (measured as TST >5, TST>10mm, QFT) https://t.co/SIkefJg909 | |
| 03 Aug 2018 | News | Higher Infection Rates for Infliximab in Psoriasis | |
| 19 Jul 2018 | News | Biomarker Combo Predicts TNF Inhibitor Responses | |
| 12 Jun 2018 | News | TNF Inhibitors Don't Increase Cancer Risk in Children | |
| 11 Jun 2018 | News | Risk of Psoriasis Complicating TNF Inhibitor Therapy | |
| 09 Apr 2018 | News | Favorable Certolizumab Safety Profile in Pregnancy | |
| 05 Mar 2018 | News | Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept | |
| 20 Feb 2018 | News | Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk | |
| 20 Feb 2018 | Social | PANTS study:Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP | |
| 12 Feb 2018 | Social | RT @uptoTate: Obesity as a predictor for poor TNFi response in IBD. Dr. U. Mahadevan #RWCS @RheumNow https://t.co/nmCljYcaqJ | |
| 10 Feb 2018 | Social | RT @uptoTate: Likelihood of achieving remission in patients who’ve failed one TNFi. Dr. M. Genovese #RWCS @RheumNow https://t.co/kFt0InT5q5 | |
| 26 Jan 2018 | Social | RheumNow Wk in Review is up. Discussing MPO bronchiectasis, $$ biologics, comorbidity in myositis, secondary TNF failure & ADAbs. Listen here https://t.co/wmVyjrzOB1 Watch there https://t.co/32q2qojDZC | |
| 25 Jan 2018 | News | Obesity Outweighs Psoriasis in Comorbidity Risk with Children |
